|
Multiple Sclerosis Clinical Trials in North Dakota
1 recruiting study across 1 city
All Trials in North Dakota
| Trial | Phase | Location |
|---|---|---|
| Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. | Phase 3 | Fargo |
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.